Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste.

MLA

Smith, Stuart J., et al. “Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 25, no. 16, Aug. 2019, pp. 5094–106. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-18-3850.

APA

Smith, S. J., Tyler, B. M., Gould, T., Veal, G. J., Gorelick, N., Rowlinson, J., Serra, R., Ritchie, A., Berry, P., Otto, A., Choi, J., Skuli, N., Estevez-Cebrero, M., Shakesheff, K. M., Brem, H., Grundy, R. G., & Rahman, R. (2019). Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 25(16), 5094–5106. https://doi.org/10.1158/1078-0432.CCR-18-3850

Chicago

Smith, Stuart J, Betty M Tyler, Toby Gould, Gareth J Veal, Noah Gorelick, Jonathan Rowlinson, Riccardo Serra, et al. 2019. “Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 25 (16): 5094–5106. doi:10.1158/1078-0432.CCR-18-3850.